Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Tirzepatide for Sale > GMP Certified Tirzepatide Raw Material Powder CAS 2023788-19-2 - Soluble in Water & DMSO
GMP Certified Tirzepatide Raw Material Powder CAS 2023788-19-2 - Soluble in Water & DMSO buy - large image1
GMP Certified Tirzepatide Raw Material Powder CAS 2023788-19-2 - Soluble in Water & DMSO buy - image1
GMP Certified Tirzepatide Raw Material Powder CAS 2023788-19-2 - Soluble in Water & DMSO buy - image2
GMP Certified Tirzepatide Raw Material Powder CAS 2023788-19-2 - Soluble in Water & DMSO buy - image3
GMP Certified Tirzepatide Raw Material Powder CAS 2023788-19-2 - Soluble in Water & DMSO buy - image4
GMP Certified Tirzepatide Raw Material Powder CAS 2023788-19-2 - Soluble in Water & DMSO buy - image5
GMP Certified Tirzepatide Raw Material Powder CAS 2023788-19-2 - Soluble in Water & DMSO buy - image6

GMP Certified Tirzepatide Raw Material Powder CAS 2023788-19-2 - Soluble in Water & DMSO

TDS 2084 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

ningbo

Brand:

beiputai

Packaging:

1kg/bags

Price valid (until):

2025-12-17

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Tirzepatide,Retatrutide,Cagrilintide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Product Description
    Shop Research-Grade Tirzepatide Powder CAS 2023788-19-2 - Long-Acting Peptide Agonist Supplier-Detailed Image 1 Shop Research-Grade Tirzepatide Powder CAS 2023788-19-2 - Long-Acting Peptide Agonist Supplier-Detailed Image 2
    The raw material powder with the CAS number 2023788 - 19 - 2 is Tirzepatide powder, a polypeptide - based raw material with significant potential in the pharmaceutical research field. Here is a detailed English introduction based on its chemical properties, quality specifications, storage requirements and application prospects:

    Tirzepatide Powder (CAS 2023788 - 19 - 2)

    Basic Information

    • Product Name: Tirzepatide
    • CAS Registry Number: 2023788 - 19 - 2
    • Alternative Name: LY3298176
    • Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
    • Molecular Weight: 4813.45
    • Amino Acid Sequence: H - Tyr - Aib - Glu - Gly - Thr - Phe - Thr - Ser - Asp - Tyr - Ser - Ile - Aib - Leu - Asp - Lys - Ile - Ala - Gln - Lys (AEEA - AEEA - γ - Glu - Eicosanedioic acid) - Ala - Phe - Val - Gln - Trp - Leu - Ile - Ala - Gly - Gly - Pro - Ser - Ser - Gly - Ala - Pro - Pro - Pro - Ser - NH₂
    • Appearance: It presents as white or off - white lyophilized powder, which is usually in a fluffy state in lyophilized form.

    Quality Specifications

    1. Purity: The purity of the peptide detected by HPLC is generally no less than 95%, and high - grade products can reach 99% or above. The total impurities are controlled below 2.0%, and the largest single impurity does not exceed 1.0%.
    2. Related Quality Indicators: The moisture content (tested by Karl Fischer method) is no more than 8.0%; the sodium ion content is ≤ 5.0%; the peptide content is not less than 85.0%. For products meeting GMP standards, the bacterial endotoxin level is extremely low, usually as low as 0.24 EU/mg, which is far below the limit of 10 EU/mg.
    3. Solubility: It is soluble in water, and its solubility in DMSO can reach 3 mg/ml (0.73 mM), which provides convenience for the preparation of experimental and research solutions.

    Storage and Transportation

    • Storage Conditions: It should be stored in a sealed manner away from light, and long - term storage requires a low - temperature environment of - 20℃ ± 5℃. After reconstitution, it can be stored at 2 - 8℃, but the storage time should not exceed 72 hours.
    • Transportation Requirements: Low - temperature cold chain transportation with dry ice at - 20℃ is adopted, and a temperature recorder is usually equipped to monitor the temperature during transportation. Suppliers can also provide transportation verification reports as required.
    • Packaging: It is vacuum - packed for low - temperature preservation. The packaging specifications can be customized according to customer needs, ranging from milligram - level small packages to kilogram - level bulk packages.

    Biological Properties and Applications

    Tirzepatide is a dual agonist of glucose - dependent insulinotropic polypeptide (GIP) and glucagon - like peptide - 1 (GLP - 1) receptors. Its core biological functions include regulating blood glucose levels, promoting weight loss, protecting cardiovascular health, and improving β - cell function.At present, this powder is mainly used in scientific research, foreign trade export and chemical reagent fields. It serves as a key raw material for research on the treatment of type 2 diabetes, obesity management and cardiovascular disease prevention. It should be noted that products supplied for research purposes are not for human use.

    Additional Advantages

    Many manufacturers producing this product have passed ISO 9001 certification and hold relevant GMP qualifications. Some manufacturers also have US FDA - registered production workshops and can provide third - party testing reports, clinical research assistance and other supporting services. Sample provision can also be provided according to customer needs to facilitate pre - use verification.

    Shop Research-Grade Tirzepatide Powder CAS 2023788-19-2 - Long-Acting Peptide Agonist Supplier-Detailed Image 3




    Shop Research-Grade Tirzepatide Powder CAS 2023788-19-2 - Long-Acting Peptide Agonist Supplier-Detailed Image 4
    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Certificates
    • GMP Certified Tirzepatide Raw Material Powder CAS 2023788-19-2 - Soluble in Water & DMSO Certificates 1 TDS

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Polypeptide

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Retatrutide,Cagrilintide

    Location:

    Room 369, Building 2, No. 600, 21st Street, Baiyang Street, Hangzhou Economic and Technological Development Zone, Zhejiang Province

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    1

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2023

           Hangzhou Beiputai Biopharmaceutical Co., Ltd. was established in 2023. It is a high-tech enterprise focusing on the research and development and sales of peptides and related derivatives. The company currently has a peptide research and development center in the Overseas Students Pioneer Park in Qiantang District, Hangzhou. It has several well-equipped peptide research and development production lines and multiple sets of large-scale peptide synthesis and analysis equipment, including imported Agilent high-performance liquid phase analysis chromatographs, AB mass spectrometers, high-performance liquid chromatography preparation instruments and other equipment. The company's main scientific researchers have more than ten years of experience in peptide research and development and can meet the personalized customization requirements of different customers. At present, we can provide: GLP-1 peptides (semaglutide/telpotide/retalutide, etc.), small molecule analog peptides, FAPI, PSMA, OCT and other radioactive imaging peptide precursors (RDC precursors), PDC peptide compounds, peptide inhibitors (aldehyde peptides/FMK/CMK/AMOK, etc.), fluorescent enzyme substrates (PNA/AMC/AFC/R110, etc.), Ser-Thr glycopeptides, isotope-labeled peptides, macrocyclic peptides, MAPS composite antigen peptides, fluorescently labeled peptides, cell-penetrating peptides, etc., to meet the application needs of different customers. At present, the company has more than 1,000 mature peptide products, and the annual output of peptides can reach more than 30kg.


      Company Profile  


  • Inquiry History
    2084 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    2023788-19-2 in unlabeled vials 10, 15 and 30 mg

    10  Feb 14, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries

    10 MG Apr 3, 2024
    United States

    Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides

    2 MT Dec 13, 2025
    Hongkong, China

    2023788-19-2

    1 KG Aug 13, 2026
    Germany

    2023788-19-2

    1 MG Jun 18, 2026
    United States

    2023788-19-2 Retatrutide

    1 G Sep 22, 2023
    United States

    2023788-19-2 Trizepatide

    10 MT Oct 29, 2023
    United States

    Tirzepatide 2023788-19-2

    Feb 19, 2024
    United States

    Tirzepatide 2023788-19-2

    10 G Oct 31, 2023
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    Dec 2, 2025
    United States

    Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2

    1 MT Jan 25, 2024
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    1 MT Oct 20, 2023
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss

    2 KG Oct 20, 2023
    United States

    supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder

    10 MG Apr 4, 2024
    United States

    COA Offer Top quality Weight Loss Peptides Tirzepatide 10mg/vial GLP-1 2023788-19-2

    1 MT Sep 10, 2023
    Kenya

    Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2

    30 MG Dec 26, 2025
    United States

    Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide

    10  Dec 30, 2024
    United Kingdom

    Manufacturer supply high quality hot sale lowest price Tirzepatide CAS NO,2023788-19-2 99% powder 2023788-19-2 Claire

    100 G Nov 4, 2023
    Canada

    99.9% Purity GLP-1 Injection Weight Loss Peptides Liraglutide Retatrutide Tirzepatide Semaglutide 5mg 10mg CAS 2023788-19-2

    2 MT Oct 22, 2023
    United Kingdom

    tirzepatide

    10 MG Oct 21, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.